Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
170 hedge funds and large institutions have $363M invested in Meridian Bioscience Inc in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 63 increasing their positions, 50 reducing their positions, and 19 closing their positions.
42% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 19
26% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 50
4% more funds holding
Funds holding: 163 → 170 (+7)
2% less capital invested
Capital invested by funds: $368M → $363M (-$5.72M)
18% less call options, than puts
Call options by funds: $139K | Put options by funds: $170K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.82M |
| 2 |
BlackRock
New York
|
+$3.39M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.52M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.21M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$22.8M |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
-$8.13M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$4.1M |
| 4 |
JP Morgan Chase
New York
|
-$4.04M |
| 5 |
Goldman Sachs
New York
|
-$3.29M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
176
HRT Financial
New York
| – | -$138K | -14,555 | Closed |
|
|
WAM
177
Weiss Asset Management
Boston,
Massachusetts
| – | -$124K | -13,100 | Closed |
|
178
Capital Fund Management (CFM)
Paris,
France
| – | -$113K | -11,900 | Closed |
|
|
PI
179
PineBridge Investments
New York
| – | -$44K | -4,633 | Closed |
|
180
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$42K | -4,430 | Closed |
|
|
IA
181
IFP Advisors
Tampa,
Florida
| – | -$20.7K | -2,200 | Closed |
|
|
HS
182
Horan Securities
Cincinnati,
United States
| – | -$13K | -1,391 | Closed |
|
|
TRCT
183
Tower Research Capital (TRC)
New York
| – | -$11K | -1,152 | Closed |
|
|
FGAM
184
Financial Gravity Asset Management
Lakeway,
Texas
| – | -$6K | -678 | Closed |
|
|
PK
185
Pflug Koory
Omaha,
Nebraska
| – | -$2K | -250 | Closed |
|
|
HIA
186
Harbor Investment Advisory
Lutherville,
Maryland
| – | +$38 | +4 | New |
|
|
PCM
187
Prelude Capital Management
New York
| – | +$216 | +23 | New |
|
VIVO Hedge Fund Activity: Q4 2019 in Review
170 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q4 2019, worth a combined $363M — down 1.6% from $368M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new VIVO positions and 19 closed out — a net gain of 8 holders — while 63 added to existing stakes and 50 trimmed.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $4.82M. The largest seller was Brown Capital Management, cutting an estimated $22.8M.
- 170 institutional investors held Meridian Bioscience Inc (VIVO) as of Q4 2019, up from 163 in Q3 2019.
- Funds reported $363M of Meridian Bioscience Inc stock for Q4 2019, down 1.6% quarter-over-quarter.
- 27 funds opened new Meridian Bioscience Inc positions in Q4 2019 and 19 closed out, a net change of +8 holders.
- The largest Meridian Bioscience Inc buyer in Q4 2019 was Point72 Asset Management, an estimated $4.82M added.
- The largest Meridian Bioscience Inc seller in Q4 2019 was Brown Capital Management, an estimated $22.8M sold.
Based on aggregated 13F filings for Q4 2019.